hiv
type
infect
transform
host
cellular
environ
favor
nich
replic
surviv
instanc
alter
cytokin
chemokin
network
observ
howev
potenti
effect
viremia
inflammatori
mediat
fulli
elucid
monocyt
macrophag
prime
target
infect
also
sourc
inflammatori
cytokin
chemokin
key
modul
immun
system
play
critic
role
recruit
new
target
cell
includ
cell
site
infect
past
year
signific
progress
made
understand
molecular
mechan
underli
interact
advent
microarray
technolog
howev
know
crucial
host
factor
influenc
relationship
report
gener
impact
host
cell
gene
express
patientderiv
b
cell
well
vitro
infect
cell
howev
role
viremia
host
cell
cytokinechemokin
express
studi
detail
infect
seri
cytokin
chemokin
induc
may
either
support
inhibit
viral
replic
exampl
cc
chemokin
macrophag
inflammatori
protein
mip
regul
upon
activ
normal
cell
express
secret
rant
inhibit
mtropic
infect
compet
viru
bind
coreceptor
contrast
report
demonstr
stimul
replic
chemokin
growthregul
induc
protein
ip
macrophag
chemoattract
protein
mcp
also
known
attract
monocyt
lymphocyt
nk
cell
vitro
express
variou
cell
type
induc
infect
macrophag
along
rant
demonstr
increas
replic
ttropic
strain
cell
recent
report
play
critic
role
neuropathogenesi
dementia
protect
human
neuron
astrocyt
nmethyldaspart
hivtatinduc
apoptosi
investig
impact
viremia
host
inflammatori
cytokinechemokin
network
specif
util
dna
microarray
approach
pbmc
rna
deriv
virem
avirem
individu
studi
report
virem
patient
show
alter
express
key
inflammatori
cytokin
chemokin
compar
avirem
individu
particular
highli
regul
mrna
protein
level
demonstr
correl
viremia
host
respons
total
avirem
virem
patient
analyz
gene
express
studi
determin
serum
concentr
patient
select
base
viral
load
avirem
virem
clinic
characterist
therapi
statu
patient
given
tabl
addit
subject
new
cohort
patient
n
recruit
gene
express
analysi
realtim
pcr
plasma
viral
load
measur
peripher
blood
drawn
edtaco
tube
store
use
viral
load
detect
standard
ultrasensit
coba
amplicor
test
version
roch
diagnost
mannheim
bdna
analyz
system
bayer
diagnost
fernwald
center
subject
except
patient
number
highli
activ
antiretrovir
therapi
haart
time
studi
written
inform
consent
subject
approv
institut
ethic
review
board
obtain
studi
heparin
venou
blood
drawn
virem
individu
maintain
viral
load
rna
copi
avirem
individu
undetect
viral
load
rna
copi
plasma
pbmc
isol
patient
convent
biochrom
ag
berlin
gradient
centrifug
cell
wash
pb
rna
extract
procedur
immedi
follow
accord
manufactur
protocol
rneasi
mini
kit
qiagen
hilden
nl
usa
rna
sampl
treat
dnasei
rnasefre
dnase
set
qiagen
elimin
genom
dna
contamin
microarray
use
studi
first
version
inflamm
array
mwg
biotech
contain
oligonucleotid
probe
inflammatori
gene
previous
valid
laboratori
well
five
housekeep
gene
probe
spot
twice
random
order
total
rna
pbmc
avirem
virem
patient
indic
legend
tabl
purifi
qiagen
rneasi
kit
follow
column
dnasei
digest
qiagen
rna
use
prepar
crna
oligo
doublestrand
cdna
synthesi
cdna
synthesi
system
roch
follow
vitro
transcript
megascript
kit
ambion
direct
manufactur
cdna
yield
determin
photometr
equal
amount
crna
deriv
total
rna
hybrid
individu
microarray
preprepar
hybrid
solut
mwg
biotech
overnight
wash
sequenti
ssc
sd
ssc
ssc
hybrid
array
scan
maxim
resolut
affymetrix
scanner
six
differ
pmt
voltag
set
fluoresc
intens
valu
channel
process
use
imagen
softwar
biodiscoveri
order
obtain
maxim
signal
intens
without
satur
effect
intens
valu
six
tiff
imag
integr
one
valu
per
probe
mavi
softwar
version
pro
mwg
biotech
mean
valu
replica
spot
measur
individu
gene
use
analysi
use
excel
highli
regul
pathogenesisassoci
gene
select
verif
realtim
pcr
approxim
pool
rna
patient
group
individu
patient
revers
transcrib
use
oligo
dt
omniscript
revers
transcriptas
qiagen
accord
manufactur
instruct
dilut
cdna
use
templat
amplifi
use
genespecif
primer
tabl
primer
design
aid
primer
express
softwar
pe
appli
biosystem
gmbh
weiterstadt
synthes
mwg
biotech
taqman
control
reagent
pe
appli
biosystem
dehydrogenas
gapdh
standard
intern
housekeep
control
amplif
perform
either
abi
prism
sd
pe
appli
biosystem
icycl
biorad
munich
use
concentr
primer
final
reaction
volum
duplic
cycl
use
sybr
green
chemistri
obtain
standard
curv
transcrib
cdna
serial
dilut
mrna
level
normal
accord
express
sampl
valu
obtain
virem
patient
express
rel
obtain
avirem
patient
set
fold
chang
gene
calcul
method
determin
level
product
avirem
virem
patient
examin
serum
individu
eighteen
virem
avirem
patient
seroneg
healthi
control
includ
avirem
major
virem
patient
receiv
antiretrovir
therapi
time
studi
sandwich
elisa
pepro
tech
london
uk
rang
pg
use
detect
serum
obtain
store
use
analysi
done
accord
manufactur
protocol
brief
chang
use
substrat
ab
kpl
md
usa
assay
done
dilut
serum
sampl
duplic
microtit
plate
nunc
adsorp
measur
nm
frozen
pbmc
virem
n
avirem
n
patient
cultur
rpmi
biochrom
ag
berlin
complet
media
approxim
cell
stimul
h
ng
phorbol
pma
sigmaaldrich
steinheim
incub
cultur
plate
corn
new
york
ny
usa
brefeldin
sigma
ad
last
h
incub
follow
antibodi
bd
bioscienc
heidelberg
apc
mous
r
system
wiesbaden
caltag
laboratori
gmbh
brauhaussteg
hamburg
use
stain
surfac
intracellular
stain
intraprep
permeabil
reagent
beckman
coulter
marseil
franc
appli
accord
manufactur
protocol
phenotyp
cell
proport
analyz
twocolor
flow
cytometri
use
facscalibur
bd
bioscienc
heidelberg
cellquest
softwar
dead
cell
exclud
base
forward
side
scatter
gate
statist
analys
two
group
subject
perform
student
ttest
evalu
three
group
perform
oneway
analysi
varianc
test
analys
done
use
prism
graphpad
softwar
packag
p
valu
consid
signific
understand
host
cellular
inflammatori
gene
respons
infect
examin
larger
rang
wellknown
inflammatori
gene
patient
whose
clinic
featur
summar
tabl
microarray
screen
four
pool
rna
gener
repres
rna
three
five
patient
avirem
virem
state
respect
addit
rna
sampl
four
individu
patient
also
analyz
separ
microarray
total
inflammatori
gene
analyz
indic
tabl
five
gene
reproduc
upregul
least
experi
gene
compris
metabol
enzym
receptor
gene
either
regul
reproduc
express
signific
level
data
shown
furthermor
could
detect
gene
reproduc
downregul
virem
patient
mrna
express
five
induc
gene
detect
dna
microarray
analyz
quantit
realtim
pcr
use
genespecif
primer
analysi
rna
pool
sampl
experi
accord
tabl
confirm
upregul
fig
also
true
reanalyz
rna
four
individu
patient
shown
fig
b
although
certain
degre
variabl
observ
two
virem
patient
overal
express
gene
clearli
higher
avirem
individu
furthermor
increas
mrna
transcript
detect
rna
sampl
deriv
addit
avirem
virem
patient
analyz
individu
significantli
higher
mrna
transcript
observ
virem
p
compar
avirem
gene
fig
confirm
consist
microarray
data
show
higher
express
virem
patient
howev
haart
statu
virem
patient
affect
mrna
express
analyz
gene
addit
vitro
infect
healthi
donor
pbmc
result
strong
induct
measur
realtim
pcr
fig
data
line
previou
find
gener
ttropic
strain
infect
cell
rather
monocyt
small
popul
monocyt
may
becom
target
cell
virus
although
formal
exclud
possibl
bystand
effect
mediat
factor
releas
cell
upon
engag
howev
report
higher
level
proinflammatori
mediat
tumor
necrosi
factor
tnf
diseas
mediat
also
known
play
role
enhanc
express
note
mrna
level
longterm
nonprogressor
n
patient
similar
avirem
patient
data
shown
collect
find
suggest
high
viremia
associ
select
set
inflammatori
host
gene
confer
greater
impact
investig
protein
level
perform
elisa
sera
healthi
donor
avirem
patient
receiv
haart
virem
patient
select
basi
high
viral
load
receiv
haart
significantli
higher
concentr
protein
observ
virem
p
comparison
avirem
individu
fig
posit
correl
p
viremia
fig
obtain
linear
regress
analysi
regress
analysi
cell
ratio
versu
point
invers
correl
p
reach
statist
signific
data
shown
moreov
addit
experi
intermedi
viral
load
patient
rang
rna
copi
reveal
similar
correl
p
suggest
product
vari
viral
load
supplementari
figur
avail
intern
immunolog
onlin
given
fact
virem
patient
elev
concentr
serum
interest
know
whether
potenc
patient
pbmc
produc
could
recapitul
vitro
twocolor
flow
cytometri
perform
previous
frozen
pbmc
sampl
order
obtain
uniform
condit
cell
stimul
pma
h
prior
stain
expect
monocyt
primari
produc
dot
plot
analysi
clearli
indic
higher
product
monocyt
deriv
virem
patient
fig
highli
signific
increas
percentag
monocyt
virem
p
compar
avirem
patient
fig
also
true
flow
cytometri
perform
use
freshli
isol
pmbc
patient
supplementari
figur
avail
intern
immunolog
onlin
furthermor
could
demonstr
strong
invers
correl
p
cell
percentag
monocyt
fig
find
suggest
virem
patient
low
cell
count
high
express
could
potenti
marker
diseas
progress
howev
could
observ
signific
statist
correl
viral
load
data
shown
except
tendenc
toward
posit
correl
data
present
base
small
cohort
patient
n
includ
six
avirem
four
virem
possibl
explan
could
monocyt
sole
contributor
found
serum
cell
secret
final
come
circul
contrast
could
detect
signific
chang
p
express
receptor
patient
monocyt
fig
indic
viremia
signific
effect
receptor
express
analyz
avirem
virem
patient
dna
microarray
approach
take
account
blood
sampl
patient
collect
longer
period
time
account
variabl
among
individu
patient
rna
sampl
divid
three
separ
microarray
experi
rna
sampl
either
pool
analyz
individu
furthermor
strict
filter
criteria
appli
identifi
gene
express
measur
level
ii
regul
experi
least
analysi
reveal
signific
effect
viremia
mrna
level
induct
line
recent
studi
siv
simian
hiv
shiv
infect
macaqu
model
hiv
encephalopathi
exclud
possibl
induct
gene
could
respons
one
two
patient
pool
sampl
extend
investig
fresh
cohort
patient
includ
previou
studi
use
realtim
pcr
approach
similar
express
pattern
mrna
observ
virem
compar
avirem
patient
result
may
impli
persist
infect
present
avirem
patient
lead
signific
upregul
inflammatori
mediat
viral
replic
detect
found
virem
patient
host
inflammatori
respons
lead
increas
mrna
express
specif
inflammatori
gene
monocyt
patient
shown
express
compar
healthi
control
regard
flow
cytometr
analysi
patientderiv
pbmc
show
clear
increas
monocyt
virem
patient
increas
percentag
monocyt
invers
correl
cell
count
sinc
low
cell
count
associ
viremia
diseas
progress
increas
express
patient
could
potenti
reflect
addit
marker
diseas
progress
induc
mani
inflammatori
diseas
includ
infect
variou
bacteri
viral
pathogen
product
specif
sever
virus
shown
induc
express
exampl
virus
human
rhinoviru
respiratori
syncyti
viru
sever
acut
respiratori
syndrom
coronaviru
shiv
best
avail
primat
model
infect
report
induc
express
recent
shown
recruit
cell
produc
monocytederiv
macrophag
dendrit
cell
lymphoid
organ
contribut
diseas
regard
vitro
infect
macrophag
alreadi
known
activ
express
may
potenti
influenc
pathogenesi
also
observ
similar
transcript
regul
gene
vitro
infect
pbmc
obtain
four
healthi
volunt
recent
studi
use
mous
model
infect
demonstr
gene
induct
brain
tissu
infect
anim
data
suggest
viremia
alter
transcript
program
host
cytokinechemokin
network
effect
promin
respect
express
transcript
regul
could
translat
product
significantli
elev
serum
concentr
observ
virem
compar
avirem
healthi
individu
furthermor
could
demonstr
posit
correl
viremia
serum
interestingli
invers
correl
cell
associ
monocyt
sinc
strong
lymphocyt
chemoattract
higher
product
host
cell
upon
infect
may
result
recruit
target
cell
site
infect
result
higher
replic
rapid
spread
viru
fig
assum
concentr
site
infect
much
higher
peripheri
henc
strong
recruit
target
cell
expect
receptor
express
major
monocyt
lesser
extent
cell
howev
could
observ
signific
effect
viremia
express
cell
suggest
concentrationdepend
surfac
recruit
target
cell
site
infect
higher
express
might
least
part
mediat
sinc
wellknown
induc
higher
level
associ
viremia
report
mani
studi
moreov
prior
exposur
monocyt
monocytederiv
macrophag
alreadi
shown
enhanc
viral
replic
treatment
proteas
inhibitor
indinavir
reduc
plasma
level
sever
immunodefici
hivinfect
individu
effect
like
explain
reduc
viral
replic
due
effect
treatment
indinavir
higher
level
previous
report
patient
plasma
howev
discrimin
virem
avirem
patient
report
regul
protein
also
mrna
level
virem
individu
potenti
role
replic
vitro
explain
pha
blast
model
infect
observ
increas
viral
titer
day
postinfect
data
shown
line
previou
report
although
provid
direct
evid
viru
replic
studi
present
strongli
suggest
integr
host
factor
pathogenesi
support
hypothesi
presum
could
act
potenti
enhanc
replic
summari
result
gene
express
profil
increas
product
virem
individu
suggest
activ
replic
manifest
virem
patient
least
part
mediat
inflammatori
chemokin
data
show
clear
correl
viremia
host
gene
respons
unravel
mechan
increas
replic
potenti
involv
could
provid
insight
understand
relationship
inhibit
increas
product
may
lead
new
therapeut
intervent
infect
